{
  "messageType": "chronicDiseaseCohorts.genReport",
  "cohortId": "c_debb178a1c4955f95e8f9db21dbcc765",
  "cohortName": "cardio_diabetes",
  "report": {
    "type": "patient_data",
    "selectedTracks": [
      {
        "behavior": "Both",
        "label": "All Inclusion Tracks",
        "color": 0,
        "comparison": "Any",
        "compareValue": 0,
        "timeRange": [
          -20,
          20
        ],
        "track": "icd9_429|icd9_425|icd9_306.2~429* ILL-DEFINED DESCRIPTIONS AND COMPLICATIONS OF HEART DISEASE|425* CARDIOMYOPATHY|306.2* CARDIOVASCULAR MALFUNCTION ARISING FROM MENTAL FACTORS"
      },
      {
        "behavior": "Both",
        "label": "All Required Tracks",
        "color": 1,
        "comparison": "Any",
        "compareValue": 0,
        "timeRange": [
          -20,
          20
        ],
        "track": "lab.25203|WZMN.med.ATORVASTATIN|WZMN.med.ROSUVASTATIN|WZMN.med.PRAVASTATIN|WZMN.med.ATORVASTATIN_AND_EZETIMIBE|WZMN.med.FLUVASTATIN~25203 HEMOGLOBIN A1C CALCULATED|ATORVASTATIN|ROSUVASTATIN|PRAVASTATIN|ATORVASTATIN AND EZETIMIBE|FLUVASTATIN"
      },
      {
        "behavior": "Both",
        "label": "All Excluded Tracks",
        "color": 2,
        "comparison": "Any",
        "compareValue": 0,
        "timeRange": [
          -20,
          20
        ],
        "track": "disease.CANCER~disease.CANCER"
      }
    ],
    "patientId": 216,
    "align": "Yes"
  }
}